TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 160 resultados LastUpdate Última actualización 03/10/2022 [10:42:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 7 nextPage   por página


METHOD FOR DETERMINING A CURRENT GLUCOSE VALUE IN A TRANSPORTED FLUID

NºPublicación: WO2022199765A1 29/09/2022

Solicitante:

EYESENSE GMBH [DE]

DE_102021202767_PA

Resumen de: WO2022199765A1

The invention relates to a method in particular for continuously determining a current glucose value in a transported fluid, in particular blood, of an organism, having the steps of: a) ascertaining a series of measurements, comprising at least two measurement values separated by time intervals, for a tissue glucose value in the tissue surrounding the transported fluid using a sensor device, b) ascertaining the tissue glucose value using the ascertained series of measurements on the basis of a measurement model in the form of a linear or non-linear function, wherein measurement values of the measurement device are assigned to tissue glucose values while taking into consideration measurement noise using a measurement model, c) providing a state transition model, the ascertained tissue glucose values being assigned at least one glucose value in the transported fluid using the at least one state transition model while taking into consideration process noise, and d) estimating the current glucose value on the basis of an approximation of at least one provided state transition model and the ascertained tissue glucose value using at least one Kalman filter in the event the measurement model is in the form of a linear function or at least one expanded Kalman fileter in the event a measurement model is in the form of a non-linear function.

traducir

THERAPY ASSIST INFORMATION AND/OR TRACKING DEVICE AND RELATED METHODS AND SYSTEMS

NºPublicación: US2022305207A1 29/09/2022

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2022305208_PA

Resumen de: US2022305207A1

A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.

traducir

NON-INVASIVE GLUCOSE LEVEL MONITORING DEVICE USING ABSORPTION SPECTROSCOPY WITH AFFORDABILITY

NºPublicación: WO2022201009A1 29/09/2022

Solicitante:

VARSHITHA DUVVURU [IN]
KUMAR RN VIMAL [IN]

Resumen de: WO2022201009A1

The non-invasive glucose level monitoring device using absorption spectroscopy with affordability is connected through the USB port of a smartphone, introducing a concept of the both smartphone and device performing master and slave roles. The device operates on drawing power from the smartphone and uses the latter's display as the output screen through its dedicated application. In the present intervention, the radiation of wavelength between 940 -1100nm of Near InfraRed is incident to the pollex (thumb) finger bed region, since the thumb finger bed region consists of a large amount of blood capillaries. As the glucose molecule C6H12O6 is optically active, thereby interaction between the Near InfraRed radiation and the glucose molecule is recorded as the absorption spectrum by the spectrometric sensor in the device.

traducir

SYSTEMS AND METHODS FOR MONITORING AND TREATING DIABETIC FOOT ULCERS

NºPublicación: US2022304621A1 29/09/2022

Solicitante:

SMITH & NEPHEW [GB]

JP_2022533382_A

Resumen de: US2022304621A1

In some aspects, a computer-implemented method is disclosed for gathering and processing sensor data to identify a risk of impacting or causing a skin injury. The computer-implemented method can include: receiving, via a computer network, sensor feature data representing output of a user sensor configured to be worn on a limb of a user; generating activity classification model output data using the sensor feature data and an activity classification model, the activity classification model output data representing likelihoods that the sensor feature data corresponds to each of a plurality of different activity classifications; determining an activity classification from the activity classification model output data; and transmitting, via the computer network, display data representing the activity classification to a computing device configured to present the display data.

traducir

EMERGENCY MEDICAMENT DOSE CONTROL

NºPublicación: WO2022204705A1 29/09/2022

Solicitante:

BETA BIONICS INC [US]

Resumen de: WO2022204705A1

Automated glucose level control system that provide therapy to a subject, such as glucose control, are disclosed. The system generates dose control signals using control algorithms configured to autonomously determine doses of insulin to be infused into a subject. When the system determines that an initial dose control signal does not indicate health-appropriate therapy, the system can modify a manual therapy instruction and transmit an emergency dose control signal to the medicament pump. Disclosed systems and devices can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject. The system can generate a backup therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.

traducir

NON-INVASIVE NON-CONTACT SYSTEM AND METHOD FOR MEASURING DIABETES MELLITUS CONDITION USING THERMAL IMAGING

NºPublicación: US2022304578A1 29/09/2022

Solicitante:

AARCA RES INC [US]

WO_2021084346_A1

Resumen de: US2022304578A1

System and method for measuring diabetes mellitus condition of a subject is disclosed. The disclosed system and method includes thermal sensors for capturing thermal images and/or videos of a body part; and a processing engine to detect a predefined region of the body part in each frame of the captured images and/or videos. The processing engine segments one or more portions from the detected predefined region in each frame of the captured images and/or videos to identify a region of interest comprising major arteries in the segmented portions. Based on the ROI, the engine extracts pixel values, representing biosignals, from each frame of the captured images and/or videos so as to determine one or more parameters associated with the hemodynamic factors and a rate of atherosclerosis of the subject. Further, a risk score for the diabetes mellitus condition based on the determined parameters using computational models is measured.

traducir

MEDICINE INJECTION AND DISEASE MANAGEMENT SYSTEMS, DEVICES, AND METHODS

NºPublicación: US2022305212A1 29/09/2022

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2022134017_A1

Resumen de: US2022305212A1

One or more embodiments of the present disclosure may include an insulin delivery system that includes an insulin delivery device, a user interface that includes multiple user-selectable icons or buttons each representing different meal characteristics, memory to store one or more user-specific dosage parameter, and a processor in communication with the memory and adapted to receive blood glucose data. The processor may also be adapted to determine initial meal characteristics associated with each of the user-selectable icons or buttons based on at least one of the user-specific dosage parameters. The processor may also be adapted to update the meal characteristics associated with each of the user-selectable icons or buttons based upon the blood glucose data.

traducir

CLOUD-CONNECTED AMBULATORY PUMP INTEGRATION

NºPublicación: US2022305202A1 29/09/2022

Solicitante:

BETA BIONICS INC [US]

Resumen de: US2022305202A1

Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.

traducir

Continuous blood glucose monitoring device

NºPublicación: AU2021229886A1 29/09/2022

Solicitante:

I SENS INC

KR_20210111940_A

Resumen de: AU2021229886A1

The present invention relates to a continuous blood glucose monitoring device, and provides a continuous blood glucose monitoring device, which has an incision area formed by means of a guide needle, in a state in which a body-attaching unit is insertively attached to a body, so as not to encompass at least a part of a region of a sensing area formed in a sensor member, so that the incision part is not formed near the sensing area, and thus the present invention can prevent a decrease in a blood glucose monitoring value that occurs because of the incision part so as to detect an accurate blood glucose monitoring value from an initial operation stage, and adjusts an insertion depth of the guide needle through an applicator when the body-attaching unit is insertively attached to the human body, so as to adjust the separation distance between the incision part and the sensing area by means of the guide needle, thereby improving blood glucose monitoring accuracy.

traducir

Continuous blood glucose measurement device

NºPublicación: AU2021232498A1 29/09/2022

Solicitante:

I SENS INC

KR_20210111934_A

Resumen de: AU2021232498A1

The present invention relates to a continuous blood glucose measurement device configured to prevent, in a state where a body attachment unit is inserted in and attached to a human body, an incision portion made by a guide needle from being formed to surround at least a part of a sensing area formed at a sensing member, whereby an incision portion is not formed around the sensing area so as to prevent the incision portion from causing a drop in a blood glucose measurement value and thus enable detection of an accurate blood glucose measurement value from the early stage of operation. Further, the guide needle has a shape not surrounding at least a part of the sensing area, so as to prevent, even without an additional device, the guide needle from forming an incision portion around the sensing area in a human body and thus enhance, by a simple structure, the accuracy of blood glucose measurement.

traducir

MINIATURE CLOSED-LOOP ARTIFICIAL PANCREAS SYSTEM

NºPublicación: US2022305201A1 29/09/2022

Solicitante:

MEDTRUM TECH INC [CN]

US_2022304597_PA

Resumen de: US2022305201A1

The invention discloses a miniature closed-loop artificial pancreas system, comprising: infusion unit configured to deliver drugs; program unit comprising input end and output end, and the input end comprises a plurality of electrically connective regions for receiving signals of analyte data in the body fluid, after the output end is electrically connected to the infusion unit, according to the received signals of analyte data in the body fluid, the program unit controls whether the infusion unit delivers drugs; an infusion cannula with conductive area, the infusion cannula is the drug infusion channel; and a plurality of electrodes for detecting analyte data in body fluid, the electrode comprising conductive-area electrode and cannula-wall electrode, and one or more cannula-wall electrodes being located on/in the wall of the infusion cannula. It takes only one insertion to perform both analyte detection and drug infusion.

traducir

REAL-TIME BLOOD GLUCOSE MONITORING APPARATUS AND MANUFACTURING METHOD THEREFOR

NºPublicación: WO2022199485A1 29/09/2022

Solicitante:

MICROTECH MEDICAL HANGZHOU CO LTD [CN]

CN_115105064_PA

Resumen de: WO2022199485A1

The present invention relates to the technical field of blood glucose monitoring, and in particular to a split-type real-time blood glucose monitoring apparatus and a manufacturing method therefor. The real-time blood glucose monitoring apparatus comprises a sensor assembly and an emitter assembly. The sensor assembly comprises a first shell, and a conductive plating, a blood glucose sensor and a battery which are arranged on the first shell. The emitter assembly comprises a second shell and a circuit board in the second shell. The conductive plating is arranged on a shell wall of the first shell and is connected to the blood glucose sensor and the battery, and the conductive plating is provided with at least one first connecting structure; and the circuit board is provided with at least one second connecting structure. By means of the technical solution provided in the present invention, a sensor assembly can be further miniaturized by means of combining a conductive plating and a shell; and connection contacts are arranged in a centralized manner, such that distribution points of the connection contacts on the sensor assembly and an emitter assembly can be reduced, and the space occupied by a contact structure can be reduced, thereby facilitating the miniaturization of a product.

traducir

Optical device for non-invasive continuous monitoring of blood glucose level and HbA1c concentration

NºPublicación: US11452469B1 27/09/2022

Solicitante:

AIYER ARUN ANANTH [US]

US_2020359939_A1

Resumen de: US11452469B1

A sensor device which is adapted for detecting target molecules in-vitro and in-vivo, comprises a MIR source emitting in 2 um to 10 um range for exciting the target species and a probe beam with orthogonal polarizations and split frequencies in the KHz. to MHz range. The probe beam measures the effects of specie concentration change and of its excitation. The evanescent fields of the orthogonally polarized beams in the probe beam undergo differential phase shifts when target species concentration changes in epidermis or when its refractive index changes due to photo-thermal excitation by the MIR beam. The phase shift is directly proportional to concentration change and refractive index change and are measured using a heterodyne interferometer operating at the same frequency as the split frequency. The measured phase shift can be related to specie concentration change in target volume.

traducir

ASSESSING DISEASE RISKS FROM USER CAPTURED IMAGES

NºPublicación: US2022301723A1 22/09/2022

Solicitante:

ADVANCED HUMAN IMAGING LTD [US]

WO_2022192948_PA

Resumen de: US2022301723A1

In some examples, an apparatus, such as a mobile phone can include an input module such as a touch screen, a camera, a processor, and computer readable medium. The camera captures one or more images of a person. The processor can use a single machine learning model to estimate the human body features of the person based on the captured images, and use the human body features to generate a disease risk assessment value associated with diabetes and cardiovascular disease risks. The human body features can include at least one or more of: 3D body shape, or body shape indicators; and one or more of: blood flow, blood pressure, heart rate, respiratory rate, heart rate variability, cardiac workload, irregular heartbeats, or stress index. The machine learning model can be trained over a set of training images.

traducir

DIABETIC RETINOPATHY DETECTION USING MACHINE LEARNING

NºPublicación: US2022301153A1 22/09/2022

Solicitante:

ACER MEDICAL INC [TW]

CN_115115569_PA

Resumen de: US2022301153A1

Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for computer aided diagnosis of a medical image. One of the methods includes processing the medical image through a machine learning (ML) model to provide a first feature representation of the medical image, wherein the ML model includes an input layer and a pooling layer, wherein the first feature representation is an output from the pooling layer, generating, by the ML model, a sequence of second feature representations of the medical image from the first feature representation of the medical image, wherein each second feature representation in the sequence of the second feature representations having a lower dimension than the first feature representation, and generating, by the ML model, an output as a last second feature representation in the sequence of the second feature representations.

traducir

ASSESSING DISEASE RISKS FROM USER CAPTURED DATA

NºPublicación: WO2022192948A1 22/09/2022

Solicitante:

ADVANCED HUMAN IMAGING LTD [AU]

US_2022301723_PA

Resumen de: WO2022192948A1

In some examples, an apparatus (100), such as a mobile phone can include an input module (102) such as a touch screen, a camera (104), a processor, and computer readable medium. The camera (104) captures one or more images of a person. The processor can use a single machine learning model (110) to estimate the human body features of the person based on the captured images, and use the human body features to generate a disease risk assessment value associated with diabetes and cardiovascular disease risks. The human body features can include at least one or more of: 3D body shape, or body shape indicators; and one or more of: blood flow, blood pressure, heart rate, respiratory rate, heart rate variability, cardiac workload, irregular heartbeats, or stress index. The machine learning model (110) can be trained over a set of training images.

traducir

ANALYTE SENSOR

NºPublicación: US2022296134A1 22/09/2022

Solicitante:

DEXCOM INC [US]

US_2022054056_A1

Resumen de: US2022296134A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transeutaneous measurement of glucose in a host.

traducir

Glucose measurement predictions using stacked machine learning models

NºPublicación: AU2021284267A1 22/09/2022

Solicitante:

DEXCOM INC

WO_2021247561_A1

Resumen de: AU2021284267A1

Glucose measurement and glucose-impacting event prediction using a stack of machine learning models is described. A CGM platform includes stacked machine learning models, such that an output generated by one of the machine learning models can be provided as input to another one of the machine learning models. The multiple machine learning models include at least one model trained to generate a glucose measurement prediction and another model trained to generate an event prediction, for an upcoming time interval. Each of the stacked machine learning models is configured to generate its respective output when provided as input at least one of glucose measurements provided by a CGM system worn by the user or additional data describing user behavior or other aspects that impact a person's glucose in the future. Predictions may then be output, such as via communication and/or display of a notification about the corresponding prediction.

traducir

Continuous glucose monitoring apparatus

NºPublicación: AU2021249765A1 22/09/2022

Solicitante:

I SENS INC

CN_115135242_PA

Resumen de: AU2021249765A1

The present invention relates to a continuous glucose monitoring apparatus, and provides a continuous glucose monitoring apparatus of which a body-attachment unit starts operating, in a state in which the body-attachment unit is inside an applicator, by the supply of power to the body-attachment unit through a user operation, such as separation and removal of a protective cap, so that the operating start time point of the body-attachment unit is formed by means of the user operation immediately before the body-attachment unit is inserted into and attached to the human body, thereby enabling the body-attachment unit to start operating at an appropriate point in time, the body-attachment unit starts operating only by simply removing the protective cap even without performing separate additional work for starting operation of the body-attachment unit, thereby improving use convenience, and an operating method for a power supply switch means that supplies battery power to the body-attachment unit is formed as various methods that are linked with a separation and removal operation of the protective cap, and thus manufacturing and use convenience can be further improved.

traducir

OPTIMIZING ANALYTE SENSOR CALIBRATION

NºPublicación: US2022296132A1 22/09/2022

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2022110553_A1

Resumen de: US2022296132A1

Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.

traducir

DETECTION AND/OR PREDICTION OF A MEDICAL CONDITION USING ATRIAL FIBRILLATION AND GLUCOSE MEASUREMENTS

NºPublicación: US2022296174A1 22/09/2022

Solicitante:

COVIDIEN LP [US]

CN_115105065_PA

Resumen de: US2022296174A1

A system comprises electrocardiogram sensing, glucose sensing circuitry, and processing circuitry. The sensing circuitry is configured to sense an electrocardiogram of a patient. The glucose sensing circuitry is configured to sense glucose levels of the patient. The processing circuitry configured to detect atrial fibrillation of the patient during a time unit based on the electrocardiogram of the patient, determine a first metric, wherein the first metric is associated with atrial fibrillation the patient experiences during the time unit, determine a second metric, wherein the second metric is associated with glucose levels of the patient during the time unit, and generate a health metric, wherein the health metric is determined based on the first and second metrics.

traducir

Methods Circuits Devices Systems and Machine Executable Code for Glucose Event Detection

NºPublicación: US2022296133A1 22/09/2022

Solicitante:

CALOSENSE LTD [IL]

Resumen de: US2022296133A1

Disclosed are methods, circuits, devices, systems and functionally associated machine executable code for glucose event detection. A system for glucose event detection includes a recursive neural network (RNN) model for generating, for a monitored subject, blood glucose level (BGL) output streams for respective, system fed, heart beats per minute (BPM) input streams of a monitored subject. A supervised training mechanism, for training the artificial recurrent neural network (RNN) model, compares model generated blood glucose level (BGL) output streams to time-aligned blood glucose level (BGL) output streams from a continuous glucose monitoring (CGM) device concurrently monitoring the same subject.

traducir

MEASUREMENT SYSTEM, MEASUREMENT APPARATUS AND STORAGE MEDIUM STORING PROGRAM

NºPublicación: US2022296135A1 22/09/2022

Solicitante:

QUANTUM OPERATION INC [JP]

CN_114650769_PA

Resumen de: US2022296135A1

This measurement system comprises: an infrared emission unit that emits first infrared light; an infrared reception unit that receives second infrared light, which is light obtained as a result of the first infrared light being reflected on a portion of the body of a measurement subject or being transmitted through a portion of the body of a measurement subject; an infrared current generation unit that applies a pulse current to the infrared emission unit; a duty control part that, on the basis of the intensity of the second infrared light, changes the duty of the pulse current applied by the infrared current generation unit; and a glucose level determination device that, on the basis of the intensity of the second infrared light, determines the blood glucose level of the measurement subject.

traducir

MINIATURIZED ANALYTE SENSOR

NºPublicación: US2022296131A1 22/09/2022

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2020155044_A1

Resumen de: US2022296131A1

The disclosed techniques include applying, using a voltage controller, multiple voltage pulses to a working electrode of a two-electrode sensor probe, and measuring, using a current sensor, the current response to the applied multiple voltage pulses. The techniques also include analyzing, using a processor, the measured current response, and calibrating, using a processor, the current sensor on the basis of the analyzed measured current response. The techniques further include determining, using a processor, a glucose concentration value on the basis of the calibrated current sensor, and transmitting, using a transmitter, the determined glucose concentration value to a receiver.

traducir

ADAPTER FOR A FLUID TRANSFER DEVICE

Nº publicación: US2022296471A1 22/09/2022

Solicitante:

ZEALAND PHARMA AS [DK]

WO_2021037502_A1

Resumen de: US2022296471A1

An adapter (650) for transferring fluid between a first device (100) and a second device (800). The adapter comprises a first end (652) for receiving the first device, wherein the first end includes a side wall for locating around the first device (100). The adapter (650) further comprises a second end (654) for engaging the first device (100), and including a retaining member (656; 658; 662), wherein the retaining member (656; 658; 662) is operable to prevent removal of the first device (100) from the adapter (650) upon engagement of the first device (100) with the second end (654). The first end (652) and the second end (654) are open on both ends to comprise a through-bore extending through the adapter (650). In some cases, the first device (100) may be a drug pen containing insulin.

traducir

Página1 de 7 nextPage por página

punteroimgVolver